Swedencare AB (SWDCF)
2.30
0.00 (0.00%)
USD |
OTCM |
Aug 26, 16:00
Swedencare Debt to Equity Ratio : 0.2481 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.2481 |
| March 31, 2026 | 0.253 |
| December 31, 2025 | 0.2707 |
| September 30, 2025 | 0.2524 |
| June 30, 2025 | 0.2613 |
| March 31, 2025 | 0.2388 |
| December 31, 2024 | 0.1824 |
| September 30, 2024 | 0.209 |
| June 30, 2024 | 0.2086 |
| March 31, 2024 | 0.2116 |
| December 31, 2023 | 0.2301 |
| September 30, 2023 | 0.224 |
| June 30, 2023 | 0.2348 |
| March 31, 2023 | 0.2544 |
| December 31, 2022 | 0.255 |
| September 30, 2022 | 0.2309 |
| June 30, 2022 | 0.2222 |
| March 31, 2022 | 0.2458 |
| December 31, 2021 | 0.2982 |
| September 30, 2021 | 0.3017 |
| June 30, 2021 | 0.1189 |
| March 31, 2021 | 0.1612 |
| December 31, 2020 | 0.1946 |
| Date | Value |
|---|---|
| September 30, 2020 | 0.1066 |
| June 30, 2020 | 0.0067 |
| March 31, 2020 | 0.0135 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.0191 |
| June 30, 2019 | 0.0588 |
| March 31, 2019 | 0.0834 |
| December 31, 2018 | 0.0916 |
| September 30, 2018 | 0.1402 |
| June 30, 2018 | 0.1881 |
| March 31, 2018 | 0.2125 |
| December 31, 2017 | 0.2291 |
| September 30, 2017 | 0.3066 |
| June 30, 2017 | 0.3462 |
| March 31, 2017 | 0.3753 |
| December 31, 2016 | 0.441 |
| September 30, 2016 | 0.1906 |
| June 30, 2016 | 0.1902 |
| March 31, 2016 | 0.9258 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.0102 |
| June 30, 2015 | 0.1059 |
| March 31, 2015 | 0.1985 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Orexo AB | 0.0365 |
| Camurus AB | 0.0232 |
| Moberg Pharma AB | 0.0026 |
| Infant Bacterial Therapeutics AB | 0.00 |
| AstraZeneca PLC | 0.7166 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.027B |
| Total Liabilities (Quarterly) | 293.44M |
| Shareholders Equity (Quarterly) | 733.43M |
| Current Ratio | 2.755 |
| Net Debt Paydown Yield | -0.36% |